Eventide Healthcare & Life Sciences FundETCHX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$1.6B
Expense ratio
2.31%
1-year return
+59.0%
3 years, a year
+13.7%
5 years, a year
+0.5%
Holdings
92
What it aims to do.
The Eventide Healthcare & Life Sciences Fund (the ?Healthcare & Life Sciences Fund? or the ?Fund?) seeks to achieve long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| GH Guardant Health Inc | 4.08% |
| MIRM Mirum Pharmaceuticals Inc. | 4.02% |
| INSM Insmed Inc | 3.78% |
| US Bank Mmda | 3.65% |
| BeLite Bio Inc | 3.30% |
| KYMR Kymera Therapeutics Inc | 3.28% |
| PCVX Vaxcyte Inc | 3.03% |
| Apogee Therapeutics Inc. | 2.96% |
| IONS Ionis Pharmaceuticals, Inc. | 2.72% |
| ARGX Argenx SE | 2.26% |
More on ETCHX.
- ETCHX overview
- ETCHX holdings
- ETCHX risk
- ETCHX costs
- ETCHX money in and out
- ETCHX share classes
- Compare ETCHX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.